Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
| ▸ | CA12 | O43570 | 2/20 | 0.60 |
| ▸ | CA9 | Q16790 | 2/20 | 0.60 |
| ▸ | CA2 | P00918 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | GBA1 | P04062 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7092060 | 0.89 | ALDH1A1 (0.70) | ALDH1A1MEN1KMT2ACA12CA9 | |
| SCHEMBL5567042 | 0.88 | ALDH1A1 (0.75) | ALDH1A1MEN1KMT2ACA12CA9 | |
| SCHEMBL7094581 | 0.87 | ALDH1A1 (0.68) | ALDH1A1MEN1KMT2ACA12CA9 | |
| SCHEMBL8213969 | 0.86 | ALDH1A1 (0.72) | ALDH1A1MEN1KMT2ACA12CA9 | |
| SCHEMBL4581466 | 0.85 | ALDH1A1 (0.71) | ALDH1A1MEN1KMT2ACA12CA9 | |
| SCHEMBL6355304 | 0.85 | ALDH1A1 (0.71) | ALDH1A1MEN1KMT2ACA12CA9 | |
| SCHEMBL10176542 | 0.84 | ALDH1A1 (0.68) | ALDH1A1MEN1KMT2ACA12CA9 | |
| SCHEMBL7201051 | 0.84 | ALDH1A1 (0.86) | ALDH1A1MEN1KMT2ACA12CA9 | |
| SCHEMBL7094852 | 0.84 | ALDH1A1 (0.79) | ALDH1A1MEN1KMT2ACA12CA9 | |
| SCHEMBL18377408 | 0.82 | SIGMAR1 (0.67) | ALDH1A1MEN1KMT2ACA2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010940-A | Citric acid-based fluorescent dye with long-life characteristic of water, and preparation method and application thereof | 西湖大学 | 2026-05-12 | — | — | CN | claimed |
| CN-122010940-A | Citric acid-based fluorescent dye with long-life characteristic of water, and preparation method and application thereof | 西湖大学 | 2026-05-12 | — | — | CN | disclosed |
| CN-110191878-B | Bicyclo [1.1.1] pentane inhibitors of dual leucine zipper (DLK) kinases for the treatment of diseases | 德州大学系统董事会 | 2023-05-26 | — | — | CN | disclosed |
| CN-110669088-B | N- (2-ethylamine) benzenesulfonylamino cordycepin derivative and preparation method and application thereof | 成都阿奇生物医药科技有限公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-110669088-A | N- (2-ethylamine) benzenesulfonylamino cordycepin derivative and preparation method and application thereof | 成都阿奇生物医药科技有限公司 | 2020-01-10 | — | — | CN | disclosed |
| WO-2019025153-A1 | USE OF SUBSTITUTED N-SULFONYL-N'-ARYL DIAMINOALKANES AND N-SULFONYL-N'-HETEROARYL DIAMINOALKANES OR SALTS THEREOF FOR INCREASING THE STRESS TOLERANCE IN PLANTS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2019-02-07 | — | — | WO | disclosed |
| US-20050182069-A1 | Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine | COSSEMENT ERIC (BE) | 2005-08-18 | — | — | US | disclosed |
| US-20050176732-A1 | Enantiomers of 1-(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine | COSSEMENT ERIC (BE) | 2005-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176732-A1 | Enantiomers of 1-(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine | QDPR, PRLHR, OPRK1 | ALDH1A1 340/4885MEN1 3989/4885KMT2A 1901/4885 |
| US-20050182069-A1 | Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine | QDPR, COMT, PRLHR | ALDH1A1 294/4885MEN1 3555/4885KMT2A 2318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.